Warby Parker (WRBY) Total Non-Current Liabilities (2020 - 2026)

Warby Parker (WRBY) posted Total Non-Current Liabilities of $359.0 million for Q1 2026, up 2.03% on a QoQ basis from $351.9 million in Q4 2025, and up 9.67% year-over-year from $327.4 million in Q1 2025.

Warby Parker (WRBY) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Warby Parker's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $359.0 million for Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 9.67% year-over-year to $359.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $359.0 million (up 9.67% YoY) and the FY2025 annual result came in at $351.9 million, up 4.89% from the prior year.
  • Total Non-Current Liabilities was $359.0 million for Q1 2026 at Warby Parker, up from $351.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $359.0 million in Q1 2026 and bottomed at $258.2 million in Q2 2023.
  • A 5-year average of $296.6 million and a median of $280.4 million in 2022 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 81.31% — and 2023, when it fell 1.12%.
  • Warby Parker's Total Non-Current Liabilities stood at $280.4 million in 2022, then dropped by 1.12% to $277.3 million in 2023, then advanced by 21.0% to $335.5 million in 2024, then advanced by 4.89% to $351.9 million in 2025, then grew by 2.03% to $359.0 million in 2026.
  • Business Quant data shows WRBY's Total Non-Current Liabilities at $359.0 million in Q1 2026, $351.9 million in Q4 2025, and $336.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 6.48 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 1.92 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 48.37 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 17.13 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 941.16 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 996.30 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 4.24 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 8.65 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 2.06 Bn
10 Warby Parker 3.00 Bn 2.71 Bn 131.04 Mn 359.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 359.03 Mn
Dec 31, 2025 351.88 Mn
Sep 30, 2025 335.95 Mn
Jun 30, 2025 339.28 Mn
Mar 31, 2025 327.39 Mn
Dec 31, 2024 335.47 Mn
Sep 30, 2024 300.22 Mn
Jun 30, 2024 287.72 Mn
Mar 31, 2024 275.53 Mn
Dec 31, 2023 277.26 Mn
Sep 30, 2023 268.91 Mn
Jun 30, 2023 258.18 Mn
Mar 31, 2023 259.96 Mn
Dec 31, 2022 280.39 Mn
Sep 30, 2022 264.37 Mn
Jun 30, 2022 259.60 Mn
Mar 31, 2022 261.57 Mn
Dec 31, 2021 154.65 Mn
Sep 30, 2021 165.33 Mn
Dec 31, 2020 133.33 Mn